DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 2.00% to $1.96 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.36% to 19,523.40 and Dow Jones Industrial Average falling 0.99% to 44,303.40.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 86.71% below its 52-week high of $14.75, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.25% to $153.12, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.35% to $25.74.
Trading volume (502,347) remained 629,662 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 7, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 07, 2025 17:27 ET (22:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。